Dec. 05. 2024
Osaka, Japan – December 5, 2024 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Motohiko Kimura) today announced the listing of five generic drugs with 10 strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 332 compounds with 786 strengths.
The list of new products
1. Rivaroxaban Tablets, OD Tablets
| Generic name | Rivaroxaban |
|---|---|
| Strengths | Tablets, OD Tablets: 10mg, 15mg |
| Brand products | Xarelto® tablets, OD tablets 10mg, 15mg |
2. Vildagliptin Tablets
| Generic name | Vildagliptin |
|---|---|
| Strengths | Tablets: 50mg |
| Brand products | Equa® Tablets 50mg |
3. Saxagliptin Tablets
| Generic name | Saxagliptin Hydrate |
|---|---|
| Strengths | Tablets: 2.5mg, 5mg |
| Brand products | ONGLYZA® Tablets 2.5mg, 5mg |
4. Ezerosu® Combination Tablets
| Generic name | Ezetimibe, Rosuvastatin Calcium |
|---|---|
| Strengths | Combination Tablets: LD, HD |
| Brand products | ROSUZET® Combination Tablets LD, HD |
5. Hydroxychloroquine Sulfate Tablets
| Generic name | Hydroxychloroquine Sulfate |
|---|---|
| Strengths | Tablets: 200mg |
| Brand products | Plaquenil® Tablets 200mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.